Dosing & Uses
Supraventricular Tachycardia
Pending FDA approval for treatment of supraventricular tachycardia, including atrial fibrillation and atrial flutter
Next:
Pharmacology
Mechanism of Action
Ultra-short acting, cardioselective, beta1 blocker that results in decreased heart rate
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
